Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Effects of anxiogenic drugs on the emission of 22- and 50-kHz ultrasonic vocalizations in adult rats.

Willadsen M, Best LM, Wöhr M, Clarke PBS.

Psychopharmacology (Berl). 2018 Aug;235(8):2435-2445. doi: 10.1007/s00213-018-4942-4. Epub 2018 Jun 16.

PMID:
29909426
2.

Effects of acute morphine withdrawal on ultrasonic vocalizations in adult rats: unchanged 50-kHz call rate and altered subtype profile.

Lin YC, Zhao LL, Clarke PBS.

Psychopharmacology (Berl). 2018 Jul;235(7):1945-1953. doi: 10.1007/s00213-018-4891-y. Epub 2018 Apr 16.

PMID:
29663018
3.

Enhancement of a visual reinforcer by D-amphetamine and nicotine in adult rats: relation to habituation and food restriction.

Wright JM, Ren S, Constantin A, Clarke PBS.

Psychopharmacology (Berl). 2018 Mar;235(3):803-814. doi: 10.1007/s00213-017-4796-1. Epub 2017 Dec 3.

PMID:
29199358
4.

Reinforcement enhancement by nicotine in adult rats: behavioral selectivity and relation to mode of delivery and blood nicotine levels.

Constantin A, Clarke PBS.

Psychopharmacology (Berl). 2018 Mar;235(3):641-650. doi: 10.1007/s00213-017-4778-3. Epub 2017 Nov 11.

PMID:
29128873
5.

Measuring G protein-coupled receptor signalling in the brain with resonance energy transfer based biosensors.

Jones-Tabah J, Clarke PB, Hébert TE.

Curr Opin Pharmacol. 2017 Feb;32:44-48. doi: 10.1016/j.coph.2016.10.008. Epub 2016 Nov 9. Review.

PMID:
27837687
6.

Effects of repeated morphine on ultrasonic vocalizations in adult rats: increased 50-kHz call rate and altered subtype profile.

Best LM, Zhao LL, Scardochio T, Clarke PB.

Psychopharmacology (Berl). 2017 Jan;234(1):155-165. doi: 10.1007/s00213-016-4449-9. Epub 2016 Oct 11.

PMID:
27730272
7.

The Effects of Electrical and Optical Stimulation of Midbrain Dopaminergic Neurons on Rat 50-kHz Ultrasonic Vocalizations.

Scardochio T, Trujillo-Pisanty I, Conover K, Shizgal P, Clarke PB.

Front Behav Neurosci. 2015 Dec 8;9:331. doi: 10.3389/fnbeh.2015.00331. eCollection 2015.

8.

Therapeutic interactions to enhance the mental health and wellness of dementia caregivers and patients.

Clarke PB, Shaw EG, Villalba JA, Alli R, Sink KM.

J Gerontol Nurs. 2013 Nov;39(11):7-10. doi: 10.3928/00989134-20130916-06. Epub 2013 Sep 24.

PMID:
24066787
9.

Inhibition of 50-kHz ultrasonic vocalizations by dopamine receptor subtype-selective agonists and antagonists in adult rats.

Scardochio T, Clarke PB.

Psychopharmacology (Berl). 2013 Apr;226(3):589-600. doi: 10.1007/s00213-012-2931-6. Epub 2012 Nov 29.

PMID:
23192317
10.

The role of dopaminergic transmission through D1-like and D2-like receptors in amphetamine-induced rat ultrasonic vocalizations.

Wright JM, Dobosiewicz MR, Clarke PB.

Psychopharmacology (Berl). 2013 Feb;225(4):853-68. doi: 10.1007/s00213-012-2871-1. Epub 2012 Sep 28.

PMID:
23052567
11.

Failure of rewarding and locomotor stimulant doses of morphine to promote adult rat 50-kHz ultrasonic vocalizations.

Wright JM, Deng L, Clarke PB.

Psychopharmacology (Berl). 2012 Dec;224(4):477-87. doi: 10.1007/s00213-012-2776-z. Epub 2012 Jul 3.

PMID:
22752383
12.

α- and β-Adrenergic receptors differentially modulate the emission of spontaneous and amphetamine-induced 50-kHz ultrasonic vocalizations in adult rats.

Wright JM, Dobosiewicz MR, Clarke PB.

Neuropsychopharmacology. 2012 Feb;37(3):808-21. doi: 10.1038/npp.2011.258. Epub 2011 Oct 26.

13.

Identification of multiple call categories within the rich repertoire of adult rat 50-kHz ultrasonic vocalizations: effects of amphetamine and social context.

Wright JM, Gourdon JC, Clarke PB.

Psychopharmacology (Berl). 2010 Jul;211(1):1-13. doi: 10.1007/s00213-010-1859-y. Epub 2010 May 6.

PMID:
20443111
14.

Lack of effect of dopaminergic denervation on caudate-putamen hyperthermia or hypothermia induced by drugs and mild stressors.

Marcangione C, Constantin A, Clarke PB.

Pharmacol Biochem Behav. 2010 Jul;96(1):32-9. doi: 10.1016/j.pbb.2010.04.003. Epub 2010 Apr 14.

PMID:
20398690
15.

Facilitation of intravenous nicotine self-administration in rats by a motivationally neutral sensory stimulus.

Sorge RE, Pierre VJ, Clarke PB.

Psychopharmacology (Berl). 2009 Dec;207(2):191-200. doi: 10.1007/s00213-009-1647-8. Epub 2009 Sep 16.

PMID:
19756529
16.

Rats self-administer intravenous nicotine delivered in a novel smoking-relevant procedure: effects of dopamine antagonists.

Sorge RE, Clarke PB.

J Pharmacol Exp Ther. 2009 Aug;330(2):633-40. doi: 10.1124/jpet.109.154641. Epub 2009 May 15.

PMID:
19448141
17.

Effects of calpain inhibition on dopaminergic markers and motor function following intrastriatal 6-hydroxydopamine administration in rats.

Grant RJ, Sellings LH, Crocker SJ, Melloni E, Park DS, Clarke PB.

Neuroscience. 2009 Jan 23;158(2):558-69. doi: 10.1016/j.neuroscience.2008.10.023. Epub 2008 Nov 1.

PMID:
19007862
18.

Rewarding and aversive effects of nicotine are segregated within the nucleus accumbens.

Sellings LH, Baharnouri G, McQuade LE, Clarke PB.

Eur J Neurosci. 2008 Jul;28(2):342-52. doi: 10.1111/j.1460-9568.2008.06341.x.

PMID:
18702705
19.

Characterization of dopamine-dependent rewarding and locomotor stimulant effects of intravenously-administered methylphenidate in rats.

Sellings LH, McQuade LE, Clarke PB.

Neuroscience. 2006 Sep 1;141(3):1457-68. Epub 2006 Jun 6.

PMID:
16753267
20.

Chronic morphine administration results in tolerance to delta opioid receptor-mediated antinociception.

Pradhan AA, Siau C, Constantin A, Clarke PB.

Neuroscience. 2006 Aug 25;141(2):947-54. Epub 2006 May 22.

PMID:
16716526
21.

Evidence for multiple sites within rat ventral striatum mediating cocaine-conditioned place preference and locomotor activation.

Sellings LH, McQuade LE, Clarke PB.

J Pharmacol Exp Ther. 2006 Jun;317(3):1178-87. Epub 2006 Feb 28.

PMID:
16507711
22.
23.
24.
25.

Long-lasting rescue of age-associated deficits in cognition and the CNS cholinergic phenotype by a partial agonist peptidomimetic ligand of TrkA.

Bruno MA, Clarke PB, Seltzer A, Quirion R, Burgess K, Cuello AC, Saragovi HU.

J Neurosci. 2004 Sep 15;24(37):8009-18.

26.

Morphine-induced changes in delta opioid receptor trafficking are linked to somatosensory processing in the rat spinal cord.

Morinville A, Cahill CM, Aibak H, Rymar VV, Pradhan A, Hoffert C, Mennicken F, Stroh T, Sadikot AF, O'Donnell D, Clarke PB, Collier B, Henry JL, Vincent JP, Beaudet A.

J Neurosci. 2004 Jun 16;24(24):5549-59.

27.

Nicotinic modulation of thalamocortical neurotransmission.

Clarke PB.

Prog Brain Res. 2004;145:253-60. Review. No abstract available.

PMID:
14650920
28.

Nicotine-dependence symptoms are associated with smoking frequency in adolescents.

O'Loughlin J, DiFranza J, Tyndale RF, Meshefedjian G, McMillan-Davey E, Clarke PB, Hanley J, Paradis G.

Am J Prev Med. 2003 Oct;25(3):219-25.

PMID:
14507528
29.

Effects of acute nicotine on hemodynamics and binding of [11C]raclopride to dopamine D2,3 receptors in pig brain.

Cumming P, Rosa-Neto P, Watanabe H, Smith D, Bender D, Clarke PB, Gjedde A.

Neuroimage. 2003 Jul;19(3):1127-36.

PMID:
12880838
30.
31.
32.
33.

Evidence for sequence-dependent and reversible nonspecific effects of PS-capped antisense treatment after intracerebral administration.

Boye SM, Pradhan AA, Grant RJ, Clarke PB.

Antisense Nucleic Acid Drug Dev. 2002 Apr;12(2):95-102.

PMID:
12074369
34.

Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers.

Dagher A, Bleicher C, Aston JA, Gunn RN, Clarke PB, Cumming P.

Synapse. 2001 Oct;42(1):48-53.

PMID:
11668590
36.

Enhancement of haloperidol-induced catalepsy by nicotine: an investigation of possible mechanisms.

Boye SM, Clarke PB.

Can J Physiol Pharmacol. 2000 Nov;78(11):882-91.

PMID:
11100936
37.

Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat.

Fraser GL, Pradhan AA, Clarke PB, Wahlestedt C.

J Pharmacol Exp Ther. 2000 Dec;295(3):1135-41.

PMID:
11082450
38.

The effects of delta agonists on locomotor activity in habituated and non-habituated rats.

Fraser GL, Parenteau H, Tu TM, Ducharme J, Perkins MN, Clarke PB.

Life Sci. 2000 Jul 14;67(8):913-22.

PMID:
10946851
39.

Antihyperalgesic effects of delta opioid agonists in a rat model of chronic inflammation.

Fraser GL, Gaudreau GA, Clarke PB, Ménard DP, Perkins MN.

Br J Pharmacol. 2000 Apr;129(8):1668-72.

40.

Nicotinic receptors modulating somatodendritic and terminal dopamine release differ pharmacologically.

Reuben M, Boye S, Clarke PB.

Eur J Pharmacol. 2000 Mar 30;393(1-3):39-49.

PMID:
10770996
41.

Antisense inhibition of delta-opioid receptor gene function in vivo by peptide nucleic acids.

Fraser GL, Holmgren J, Clarke PB, Wahlestedt C.

Mol Pharmacol. 2000 Apr;57(4):725-31.

PMID:
10727518
42.

Effects of nicotine and chlorisondamine on cerebral glucose utilization in immobilized and freely-moving rats.

Marenco T, Bernstein S, Cumming P, Clarke PB.

Br J Pharmacol. 2000 Jan;129(1):147-55.

43.

Nicotine-evoked [3H]5-hydroxytryptamine release from rat striatal synaptosomes.

Reuben M, Clarke PB.

Neuropharmacology. 2000 Jan 4;39(2):290-9.

PMID:
10670424
44.

Characterization of [125I]AR-M100613, a high-affinity radioligand for delta opioid receptors.

Fraser GL, Labarre M, Godbout C, Butterworth J, Clarke PB, Payza K, Schmidt R.

Peptides. 1999 Nov;20(11):1327-35.

PMID:
10612447
45.

International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits.

Lukas RJ, Changeux JP, Le Novère N, Albuquerque EX, Balfour DJ, Berg DK, Bertrand D, Chiappinelli VA, Clarke PB, Collins AC, Dani JA, Grady SR, Kellar KJ, Lindstrom JM, Marks MJ, Quik M, Taylor PW, Wonnacott S.

Pharmacol Rev. 1999 Jun;51(2):397-401. Review. No abstract available.

PMID:
10353988
46.

Nicotinic receptors in the rat prefrontal cortex: increase in glutamate release and facilitation of mediodorsal thalamo-cortical transmission.

Gioanni Y, Rougeot C, Clarke PB, Lepousé C, Thierry AM, Vidal C.

Eur J Neurosci. 1999 Jan;11(1):18-30.

PMID:
9987008
47.
48.
49.

Tobacco smoking, genes, and dopamine.

Clarke PB.

Lancet. 1998 Jul 11;352(9122):84-5. No abstract available.

PMID:
9672270
50.

Supplemental Content

Loading ...
Support Center